Interagency Committee on Smoking and Health (ICSH), 37876-37877 [2019-16536]

Download as PDF 37876 Federal Register / Vol. 84, No. 149 / Friday, August 2, 2019 / Notices information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two-to-three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). FOR FURTHER INFORMATION CONTACT: Mr. Curtis E. Glover, Sr., Procurement Analyst, Office of Government-wide Acquisition Policy, GSA, 202–501– 1448, or email curtis.glover@gsa.gov. SUPPLEMENTARY INFORMATION: A. OMB Number, Title, and Any Associated Form(s) 9000–0071, Price Redetermination. jbell on DSK3GLQ082PROD with NOTICES B. Needs and Uses FAR 16.205, Fixed-price contracts with prospective price redetermination, provides for firm fixed prices for an initial period of the contract and prospective redetermination of the price, at stated times during performance, during subsequent periods of performance. Prospective price redetermination is used in negotiated contracts when it is possible to establish a firm fixed price for an initial period, but not for subsequent periods of contract performance. FAR clause 52.216–5, Price RedeterminationProspective, is included in these solicitations and contracts and requires a contractor to submit to the Government— • Within an agreed upon timeframe, (1) proposed prices for the upcoming contract period, (2) a statement of costs incurred for the most recent period of performance, and (3) any supporting or relevant documentation; and, • During periods where firm prices have not been established, a quarterly statement that includes a breakdown of total contract prices, costs, and profit incurred and all invoices accepted for delivered items or services for which final prices have not been established. FAR 16.206, Fixed price contracts with retroactive price redetermination, provides for a fixed ceiling price, and retroactive price redetermination within the ceiling after completion of the contract. Retroactive price redetermination is used in research and development contracts valued at $150,000 or less when a firm fixed price cannot be negotiated and the contract amount and short performance period make the use of any other fixed-price contract type impracticable. FAR clause 52.216–6, Price Redetermination— Retroactive, is included in these solicitations and contracts and requires contractors to submit to the Government— VerDate Sep<11>2014 18:02 Aug 01, 2019 Jkt 247001 • Within an agreed upon timeframe after completion of the contract, (1) the proposed prices, (2) all costs incurred in performing the contract, and (3) any supporting or relevant documentation; and, • Until final price redetermination has been completed, a quarterly statement that includes a breakdown of total contract prices, costs, and interim profit incurred and all invoices accepted for delivered items. Contracting officers use the information submitted by respondents to accurately determine the price adjustments to be made under the contract or order in accordance with the clause. C. Annual Reporting Burden Respondents: 33. Total Annual Responses: 232. Total Burden Hours: 1,856. Affected Public: Business or other forprofit entities. D. Public Comment A 60-day notice was published in the Federal Register at 84 FR 18038 on April 29, 2019. No comments were received. Obtaining Copies: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0071, Price Redetermination, in all correspondence. Dated: July 29, 2019. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2019–16501 Filed 8–1–19; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Interagency Committee on Smoking and Health (ICSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Interagency SUMMARY: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Committee on Smoking and Health (ICSH). This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. For foreign nationals or non-U.S. citizens, pre-approval is required (please contact Monica Swann, 202–245–0552, zqe0@cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulation, Subpart 101–20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 135 people and there are 50 lines/ports available. The public is also welcome to listen to the meeting by dialing: Toll Free Phone: (888) 790–1712 Participant Passcode: 9556145. Participants will be able participate for the visual portion of the meeting by the following link: https://www.hhs.gov/ live/. DATES: The meeting will be held on September 9, 2019, 9:00 a.m. to 4:00 p.m., EDT. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW, Washington, DC 20201, Telephone: (202)775–0800. FOR FURTHER INFORMATION CONTACT: Simon McNabb, Designated Federal Officer, Interagency Committee on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 395 E Street SW, Washington, DC 20024, telephone (202) 245–0550; email bol1@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Interagency Committee on Smoking and Health shall provide advice and guidance to the Secretary, Department of Health and Human Services (HHS), regarding: (a) Coordination of research, educational programs, and other activities within the Department that relate to the effect of smoking on human health and on coordination of these activities, with similar activities of other Federal and private agencies; and (b) establishment and maintenance of liaisons with appropriate private entities, other E:\FR\FM\02AUN1.SGM 02AUN1 Federal Register / Vol. 84, No. 149 / Friday, August 2, 2019 / Notices Federal agencies, and State and local public agencies, regarding activities relating to the effect of cigarette smoking on human health. Matters To Be Considered: The agenda will include discussions on ‘‘Empowering Youth and Youth Influencers to Prevent the Use of Emerging Tobacco Products’’ and the objective of the meeting is Identify federal actions to empower youth, parents, educators, health care professionals, and others who influence youth and young adults to prevent the initiation and use of e-cigarettes and other emerging tobacco products. Requests to make oral presentations should be submitted in writing to the contact person listed. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–16536 Filed 8–1–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of closed meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). DATES: The meeting will be held on August 27, 2019 09:00 a.m. to 05:00 p.m., EDT (CLOSED). ADDRESSES: In-Person and Teleconference; 4770 Buford Highway NE, Atlanta, GA 30341. FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., jbell on DSK3GLQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:02 Aug 01, 2019 Jkt 247001 M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–3953, Email address: NCIPCBSC@cdc.gov. SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Chief Operating Officer, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. Purpose: The Board will: (1) Conduct, encourage, cooperate with, and assist other appropriate public health authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases, and other impairments; (2) assist States and their political subdivisions in preventing and suppressing communicable and noncommunicable diseases and other preventable conditions and in promoting health and well-being; and (3) conduct and assist in research and control activities related to injury. The BSC, NCIPC makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury prevention goals and provides evidence in injury preventionrelated research and programs. The Board also provides advice on the appropriate balance of intramural and extramural research, and the structure, progress and performance of intramural programs. The Board is designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to funding opportunity announcements as they relate to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters To Be Considered: The agenda will include discussions on Secondary Peer Review of extramural research grant and cooperative agreement applications received in response to five (5) Notice of Funding Opportunities (NOFO): RFA–CE19–002—Research Grants to Identify Effective Strategies for Opioid Overdose Prevention; RFA– PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 37877 CE19–003—Evaluation of Return to School Programs for Traumatic Brain Injury; RFA–CE19–005—Research Grants for Preventing Violence and Violence-Related Injury (R01); RFA– CE19–006—Grants to Support New Investigators in Addressing CrossCutting Violence Prevention and Opioid Overdose Prevention and; funding notices for Small Business Innovation Research—PA–18–573–PHS 2018–02 Omnibus Solicitation of the NIH for Small Business Innovation Research Grant Applications (Parent SBIR [R43/ R44] Clinical Trial Required) and/or PA–18–574–PHS 2018–02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/ R44] Clinical Trial Not Allowed). Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–16534 Filed 8–1–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. The meeting is also open to the public via webcast. If you wish to attend in person or by webcast, please see the NIOSH website to register (https:// www.cdc.gov/niosh/bsc/) or call (404– 498–2539) at least five business days in advance of the meeting. Teleconference SUMMARY: E:\FR\FM\02AUN1.SGM 02AUN1

Agencies

[Federal Register Volume 84, Number 149 (Friday, August 2, 2019)]
[Notices]
[Pages 37876-37877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16536]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Interagency Committee on Smoking and Health (ICSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting for the Interagency Committee on Smoking and Health 
(ICSH). This meeting is open to the public; however, visitors must be 
processed in accordance with established federal policies and 
procedures. For foreign nationals or non-U.S. citizens, pre-approval is 
required (please contact Monica Swann, 202-245-0552, [email protected] at 
least 10 days in advance for requirements). All visitors are required 
to present a valid form of picture identification issued by a state, 
federal or international government. As required by the Federal 
Property Management Regulations, Title 41, Code of Federal Regulation, 
Subpart 101-20.301, all persons entering in or on Federal controlled 
property and their packages, briefcases, and other containers in their 
immediate possession are subject to being x-rayed and inspected. 
Federal law prohibits the knowing possession or the causing to be 
present of firearms, explosives and other dangerous weapons and illegal 
substances. The meeting room accommodates approximately 135 people and 
there are 50 lines/ports available. The public is also welcome to 
listen to the meeting by dialing:
    Toll Free Phone: (888) 790-1712 Participant Passcode: 9556145. 
Participants will be able participate for the visual portion of the 
meeting by the following link: https://www.hhs.gov/live/.

DATES: The meeting will be held on September 9, 2019, 9:00 a.m. to 4:00 
p.m., EDT.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW, Washington, DC 
20201, Telephone: (202)775-0800.

FOR FURTHER INFORMATION CONTACT: Simon McNabb, Designated Federal 
Officer, Interagency Committee on Smoking and Health, National Center 
for Chronic Disease Prevention and Health Promotion, Centers for 
Disease Control and Prevention, 395 E Street SW, Washington, DC 20024, 
telephone (202) 245-0550; email [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Interagency Committee on Smoking and Health shall 
provide advice and guidance to the Secretary, Department of Health and 
Human Services (HHS), regarding: (a) Coordination of research, 
educational programs, and other activities within the Department that 
relate to the effect of smoking on human health and on coordination of 
these activities, with similar activities of other Federal and private 
agencies; and (b) establishment and maintenance of liaisons with 
appropriate private entities, other

[[Page 37877]]

Federal agencies, and State and local public agencies, regarding 
activities relating to the effect of cigarette smoking on human health.
    Matters To Be Considered: The agenda will include discussions on 
``Empowering Youth and Youth Influencers to Prevent the Use of Emerging 
Tobacco Products'' and the objective of the meeting is Identify federal 
actions to empower youth, parents, educators, health care 
professionals, and others who influence youth and young adults to 
prevent the initiation and use of e-cigarettes and other emerging 
tobacco products. Requests to make oral presentations should be 
submitted in writing to the contact person listed. All requests must 
contain the name, address, telephone number, and organizational 
affiliation of the presenter. Agenda items are subject to change as 
priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-16536 Filed 8-1-19; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.